Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia
- PMID: 3304809
- DOI: 10.1111/j.1475-097x.1987.tb00169.x
Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia
Abstract
Soluble proteins synthesized and released by phagocytic cells may be responsible for the protein and energy wasting frequently observed during catabolic states, including cancer cachexia. This hypothesis is based upon the observation that many of the hosts's metabolic responses to infection, inflammation, accidental trauma and some forms of cancer are remarkably similar. Anorexia and degradation of skeletal and connective tissue protein, as well as increases in hepatic protein synthesis and energy expenditure, can all be reproduced by the administration of activated macrophage products. During inflammatory states, including active tumour growth, increased production of some cytokines, including interleukin 1 and tumour necrosis factor-alpha (cachectin), have been observed. If these monokines serve as metabolic inducers, then efforts to block therapeutically the actions of macrophage-secreted substances may play a role in slowing the progression of tissue-wasting associated with catabolic states, particularly due to malignant tumours.
Similar articles
-
Endogenous cachectin/tumour necrosis factor-alpha production contributes to experimental cancer-associated cachexia.Cancer Surv. 1989;8(4):853-9. Cancer Surv. 1989. PMID: 2701731 Review.
-
Pathophysiology of cancer cachexia.Support Care Cancer. 1993 Nov;1(6):290-4. doi: 10.1007/BF00364965. Support Care Cancer. 1993. PMID: 8156245 Review.
-
Cytokines and cancer anorexia cachexia syndrome.Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10. Am J Hosp Palliat Care. 2008. PMID: 18403577 Review.
-
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.J Exp Med. 1985 Dec 1;162(6):2163-8. doi: 10.1084/jem.162.6.2163. J Exp Med. 1985. PMID: 2999289 Free PMC article.
-
Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.Am J Physiol. 1989 Mar;256(3 Pt 2):R659-65. doi: 10.1152/ajpregu.1989.256.3.R659. Am J Physiol. 1989. PMID: 2784290
Cited by
-
Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.Surg Today. 1998;28(9):884-8. doi: 10.1007/s005950050247. Surg Today. 1998. PMID: 9744395
-
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.J Clin Invest. 1992 May;89(5):1681-4. doi: 10.1172/JCI115767. J Clin Invest. 1992. PMID: 1569207 Free PMC article.
-
Weight loss in obese mice persistently infected with lymphocytic choriomeningitis virus is not associated with elevated tumor necrosis factor/cachectin activity in peritoneal macrophages.Am J Pathol. 1988 Sep;132(3):586-92. Am J Pathol. 1988. PMID: 3414785 Free PMC article.
-
Role of prostaglandins in tumour necrosis factor induced weight loss.Br J Cancer. 1989 Jul;60(1):51-5. doi: 10.1038/bjc.1989.218. Br J Cancer. 1989. PMID: 2803915 Free PMC article.
-
The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis.Int J Mol Sci. 2019 Apr 22;20(8):1962. doi: 10.3390/ijms20081962. Int J Mol Sci. 2019. PMID: 31013615 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources